Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04199000 · ClinicalTrials.gov registry record
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
A clinical trial of Congenital Disorders of Glycosylation, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 500
- Enrollment target
- 12
- Study locations
NCT04199000 is a study of Congenital Disorders of Glycosylation that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 500 participants. The trial reports 12 study locations across 10 states.
The verdict
NCT04199000, a study of Congenital Disorders of Glycosylation, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of this research is to study the natural history of congenital disorders of glycosylation and its causes and treatments.
Conditions Studied
Study Locations (12)
Minnesota
- University of Minnesota - Minneapolis
- Mayo Clinic in Rochester - Rochester
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- Children's Hospital of Pittsburgh - Pittsburgh
California
- Rady Children's Hospital - San Diego
Colorado
- Children's Hospital of Colorado - Aurora
Florida
- Mayo Clinic Florida - Jacksonville
Louisiana
- Tulane University School of Medicine - New Orleans
Massachusetts
- Boston Children's Hospital - Boston
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2030-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04199000
The ClinicalTrials.gov registry entry for NCT04199000 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Disorders of Glycosylation appearing as the primary indexed condition, and to 0 interventions.
NCT04199000 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Minnesota, Pennsylvania, California.
Frequently Asked Questions
What is clinical trial NCT04199000 about?
NCT04199000 is a clinical study titled "Clinical and Basic Investigations Into Congenital Disorders of Glycosylation". The purpose of this research is to study the natural history of congenital disorders of glycosylation and its causes and treatments.
What is the current status of trial NCT04199000?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2019-10-08. Estimated completion is 2030-07-31.
What conditions does trial NCT04199000 study?
This clinical trial studies the following conditions: Congenital Disorders of Glycosylation.
Who is sponsoring clinical trial NCT04199000?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04199000 being conducted?
This trial has 12 study locations across California, Colorado, Florida, Louisiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Disorders of Glycosylation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.